Cargando…
Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators
BACKGROUND: Implantation of implantable cardioverter-defibrillators (ICD) from the left pectoral region is the standard therapeutical method. Increasing numbers of system revisions due to lead dysfunction and infections will consecutively increase the numbers of right-sided implantations. The reliab...
Autores principales: | Keyser, Andreas, Hilker, Michael K, Ücer, Ekrem, Wittmann, Sigrid, Schmid, Christof, Diez, Claudius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639089/ https://www.ncbi.nlm.nih.gov/pubmed/23577747 http://dx.doi.org/10.1186/1749-8090-8-77 |
Ejemplares similares
-
Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
por: Hauck, Christian, et al.
Publicado: (2021) -
Long-Range Real Migration of Implantable Cardioverter Defibrillator Lead
por: Keyser, Andreas, et al.
Publicado: (2015) -
Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
por: Hauck, Christian, et al.
Publicado: (2022) -
Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016) -
Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with “acquired mesocardia”
por: Prousi, George S., et al.
Publicado: (2022)